TORONTO, Feb. 24 /CNW/ - Alegro Health Corp. (TSX-V: AGO), a provider of
medical, surgical and disability management services, today announced that Mr.
Paul Godard has tendered his resignation as Chief Financial Officer. The
Company also announced effective immediately, the appointment of Mr. Robert
Wardell as Financial Consultant to Alegro during this period of transition.
"We thank Paul for his energy and hard work. He has made a strong
contribution to Alegro and we wish him the best with his future endeavours,"
said Brenda Rasmussen, President and Chief Executive Officer of Alegro Health
Corp. "We also welcome Robert Wardell. His extensive public company and
financial management experience will prove invaluable as we work to grow our
business and seek a permanent Chief Financial Officer."
Mr. Wardell was most recently the Vice-President, Finance and Chief
Financial Officer of Victory Nickel Inc., a publicly traded mining company on
the Toronto Stock Exchange. Mr. Wardell also serves on the board of several
Canadian publicly listed companies including Phoenix Coal Inc., Katanga Mining
Limited and Allied Nevada Gold Corp. From 1986 to 2006, he was a senior audit
partner with Deloitte & Touche LLP. Mr. Wardell is a member of the Institute
of Chartered Accountants of Ontario and a former member of the Canadian
Institute of Chartered Accountants Emerging Issues Committee.
About Alegro Health Corp.
Alegro Health Corp. is a leading healthcare services provider capturing
high value opportunities by providing additional access to select quality
healthcare services. Through its divisions - Disability & Rehabilitation
Management and Surgical/Hospital Services - Alegro is delivering additional
resources to the Canadian public healthcare services and addressing the
growing demand for private and enhanced out-of-pocket healthcare services.
With superior knowledge of the healthcare industry, extensive and trusted
relationships with payers, physicians, and government agencies, Alegro is
pursuing a vertically integrated approach and an aggressive acquisition
strategy to achieve its growth objectives. Alegro is listed on the TSX Venture
Exchange under the symbol AGO. For further information, please visit
For further information:
For further information: Brenda Rasmussen, President and CEO, Alegro
Health, (416) 927-8400, email@example.com; Michael Moore, Investor
Relations, Equicom Group, (416) 815-0700 ext. 241, firstname.lastname@example.org